Andrea Agostini1, Mitchell Raeside1, Richard Do1, Amita Shukla-Dave2, David Aramburu Nunez2, Ramesh Paudyal2, Olga Smelianskaia1, Maggie Fung3, Monika Khan1, David Kelsen4, Gabriella Carollo5, and Lorenzo Mannelli1
1Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY, United States, 2Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY, United States, 3Global MR Applications and Workflow, GE Healthcare, New York, NY, United States, 4Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, United States, 5Saint Vincent Ferrer High School, New York, NY, United States
Synopsis
The aim of the study is the
qualitative and quantitative evaluation of Diffusion-weighted images (DWI) with
reduced field-of-view (rFOV), that are incorporated into a fast rapid MR
pancreas screening protocol (MRpsp). We are developing a fast rapid MRpsp to be
performed in carriers of BRCA mutations after a breast MRI, using the built-in
body coil of a 3T magnet without repositioning a patient who is in the prone
position. 15 patients were scanned. For b-values <100 s/mm2, b=20
s/mm2 DWI had the best contrast-to-noise and signal-to-noise ratios.
Among b-values >100 s/mm2, b=250 s/mm2 DWI showed the
highest diagnostic information.Purpose
Patients with mutations of BRCA
have higher risk of pancreatic cancer (3-10 fold for BRCA2; 2.6-3.6 fold for
BRCA1
1), and thus should be considered for pancreatic screening
programs
2. At present there is no accepted screening protocol, due
to uncertainties in diagnostic performance, potential costs, and invasiveness
of some diagnostic tests.
Taking advantage of the fact that
carriers of BRCA mutations undergo MRI screening for breast cancer, we are
developing and optimizing a < 10 minutes fast MR pancreas screening protocol
(MRpsp) to be performed at the conclusion of a breast MRI without patient
repositioning and using the built-in-body-coil. The protocol includes: axial
and coronal T2, axial T1, and reduced Field of View (rFOV) diffusion weighted
images (DWI).
The aims of this study are:
1) To
compare the quality of different b values in rFOV DWI, and
2) to
evaluate the inter-reader agreement in normal pancreas ADC measurements.
Methods
This prospective study was
approved by the local IRB.
Inclusion criteria were: female
patients who are BRCA1 or BRCA2 mutation carriers undergoing breast MR
screening.
MRpsp was performed with a 3T
magnet (MR 750, GE Healthcare, United States) after a contrast enhanced breast
MR (Multihance, 0.2 ml/kg, Bracco Diagnostics, United States) with patients in the
prone position and using the built-in-body-coil. DWI sequence parameters are
reported in table 1.
DWI of the pancreatic head, body,
and tail was evaluated in consensus by two radiologists with a 5 points
semi-quantitative score: 1= full diagnostic information is present; 2= most of
diagnostic information is present; 3= some diagnostic information is present; 4=
minimal diagnostic information is present; 5= non diagnostic.
Quantitative analysis was
performed by two radiologists with a commercially available post-processing
workstation (Advantage Workstation 4.6, GE Healthcare, United States) placing
circular, 5 mm diameter Region-of-Interest (ROI) in pancreatic head, body, and tail,
and in peripancreatic fat. ROIs were automatically propagated through all the evaluated
series and average signal intensity (SI) and standard deviation (SD) per ROI
were recorded. Signal-to-Noise Ratio (SNR) was calculated as ROISI,Pancreas/ROISD,Pancreas.
Contrast-to-Noise Ratio (CNR) was calculated as (ROISI,Pancreas–ROISI,Fat)/ROISD,Fat.
Inter-reader agreement for ADC measurements was
calculated with Intraclass Correlation Coefficient. For DWI, preliminary statistical
analysis was conducted separately for lower b-value images (b<100 s/mm2)
and for higher b-value images (b>100 s/mm2), considering average of measures
of both readers without correction for the NEX variability for different b-values.
Non-parametric tests were used, and p values <0.05 were considered significant.
Results
Fifteen patients were imaged
(Figure 1).
All low b-value (<100 s/mm2)
DWI were ranked as fully diagnostic with the exception of one pancreatic
tail (subject 2, rank 3= some diagnostic information, due to inconsistent
breathing). As expected, DWI with b-values >100 s/mm2 showed higher
variability in diagnostic image quality: b=250 s/mm2 DWI was ranked significantly
better than b=500 s/mm2 and b= 800 s/mm2 DWI (Wilcoxon, p<0.05).
No other significant differences were recorded (Table 2).
For DWI with b<100 s/mm2,
SNR was significantly higher in the pancreatic head, body and tail when using b=20
s/mm2. For DWI with b>100
s/mm2, no relevant differences were recorded in terms of SNR (Table
3).
For DWI with b<100 s/mm2
images CNR was significantly higher in the pancreatic head, body and tail, when
using b=20 s/mm2. For b>100 s/mm2 images, no significant
differences in CNR were demonstrated (Table 3).
ADC values (x10-3 mm2/s)
in pancreatic head, body and tail were respectively for reader 1: 1.35; 1.69;
and 1.65; for reader 2: 1.47; 1.55; and 1.59. Values were comparable with the
ranges reported in the literature3. Intra-class correlation coefficients
between the two readers measuring ADC in different pancreatic regions were
0.6860 (head), 0.8800 (body), and 0.7143 (tail) (Table 4).
Conclusion
All rFOV DWI obtained with built-in-body
coil and patient in prone position were of diagnostic quality. At b<100 s/mm
2, all images were
of high diagnostic quality. Among b<100 s/mm
2 the highest SNR and
CNR were obtained when using, b=20 s/mm
2. Among b>100 s/mm
2 qualitatively
better images were obtained using b=250 s/mm
2. Limited inter-reader
agreement was demonstrated for ADC measurements of the pancreas.
Acknowledgements
No acknowledgement found.References
1. Chang
MC, Wong JM, Chang YT, et al. Screening and early detection of pancreatic
cancer in high risk population. World J Gastroenterol 2014; 20(9):
2358-2364.
2. Canto
MI, Harinck F, Hruban RH, et al. International Cancer of the Pancreas Screening
(CAPS) Consortium summit on the management of patients with increased risk for
familial pancreatic cancer. Gut
2013;62:339–347.
3. Barral
M, Taouli, Guiu B, et al. Diffusion-weighted MR Imaging of the Pancreas:
Current Status and Recommendations. Radiology
2015; 274(1): 45-63.